Canada markets open in 2 hours 19 minutes

Fennec Pharmaceuticals Inc. (FRX.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
11.13+0.13 (+1.18%)
At close: 3:57PM EDT
Full screen
Previous Close11.00
Open11.18
Bid10.99 x 0
Ask11.21 x 0
Day's Range11.00 - 11.18
52 Week Range7.28 - 12.42
Volume338
Avg. Volume861
Market Cap289.457M
Beta (5Y Monthly)-0.01
PE Ratio (TTM)N/A
EPS (TTM)-0.87
Earnings DateNov. 15, 2021 - Nov. 19, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Zacks

    4 Breakout Stocks for Impressive Returns

    SB, VTSI, FENC and APYX qualified the screen for breakout stocks for today.

  • GlobeNewswire

    Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences

    RESEARCH TRIANGLE PARK, N.C., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company focused on the development of PEDMARK™ (a unique formulation of sodium thiosulfate) for the prevention of platinum-induced ototoxicity in pediatric patients, today announced that management will participate in three upcoming virtual investor conferences, including H.C. Wainwright 23rd Annual Global Investment Conference taking place September 13

  • GlobeNewswire

    Fennec Pharmaceuticals Announces Second Quarter 2021 Financial Results and Provides Business Update

    ~ FDA Prescription Drug User Fee Act (PDUFA) Target Action Date Set for November 27, 2021 ~ ~ If Approved by the FDA, PEDMARK™ Stands to Be the First Therapy for the Prevention of Cisplatin-Induced Hearing Loss in Children ~ ~ Company Has Approximately $27 Million in Cash and Cash Equivalents ~ RESEARCH TRIANGLE PARK, N.C., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company focused on the development of PEDMARK™ (a unique for